These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 33220925)

  • 1. T-cell dysregulation in COVID-19.
    Kalfaoglu B; Almeida-Santos J; Tye CA; Satou Y; Ono M
    Biochem Biophys Res Commun; 2021 Jan; 538():204-210. PubMed ID: 33220925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis.
    Kalfaoglu B; Almeida-Santos J; Tye CA; Satou Y; Ono M
    Front Immunol; 2020; 11():589380. PubMed ID: 33178221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent SARS-CoV-2-specific T- and B-cell responses in severe but not mild COVID-19 patients.
    Oja AE; Saris A; Ghandour CA; Kragten NAM; Hogema BM; Nossent EJ; Heunks LMA; Cuvalay S; Slot E; Linty F; Swaneveld FH; Vrielink H; Vidarsson G; Rispens T; van der Schoot E; van Lier RAW; Ten Brinke A; Hombrink P
    Eur J Immunol; 2020 Dec; 50(12):1998-2012. PubMed ID: 33073359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild Cytokine Elevation, Moderate CD4
    Jia R; Wang X; Liu P; Liang X; Ge Y; Tian H; Chang H; Zhou H; Zeng M; Xu J
    Virol Sin; 2020 Dec; 35(6):734-743. PubMed ID: 32699972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System.
    Peng X; Ouyang J; Isnard S; Lin J; Fombuena B; Zhu B; Routy JP
    Front Immunol; 2020; 11():596631. PubMed ID: 33384690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation induces excessive T cell cytotoxicity in severe COVID-19.
    Georg P; Astaburuaga-García R; Bonaguro L; Brumhard S; Michalick L; Lippert LJ; Kostevc T; Gäbel C; Schneider M; Streitz M; Demichev V; Gemünd I; Barone M; Tober-Lau P; Helbig ET; Hillus D; Petrov L; Stein J; Dey HP; Paclik D; Iwert C; Mülleder M; Aulakh SK; Djudjaj S; Bülow RD; Mei HE; Schulz AR; Thiel A; Hippenstiel S; Saliba AE; Eils R; Lehmann I; Mall MA; Stricker S; Röhmel J; Corman VM; Beule D; Wyler E; Landthaler M; Obermayer B; von Stillfried S; Boor P; Demir M; Wesselmann H; Suttorp N; Uhrig A; Müller-Redetzky H; Nattermann J; Kuebler WM; Meisel C; Ralser M; Schultze JL; Aschenbrenner AC; Thibeault C; Kurth F; Sander LE; Blüthgen N; Sawitzki B;
    Cell; 2022 Feb; 185(3):493-512.e25. PubMed ID: 35032429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-1-Expressing SARS-CoV-2-Specific CD8
    Rha MS; Jeong HW; Ko JH; Choi SJ; Seo IH; Lee JS; Sa M; Kim AR; Joo EJ; Ahn JY; Kim JH; Song KH; Kim ES; Oh DH; Ahn MY; Choi HK; Jeon JH; Choi JP; Kim HB; Kim YK; Park SH; Choi WS; Choi JY; Peck KR; Shin EC
    Immunity; 2021 Jan; 54(1):44-52.e3. PubMed ID: 33338412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
    Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z
    JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity.
    Lamadrid P; Alonso-Peña M; San Segundo D; Arias-Loste M; Crespo J; Lopez-Hoyos M
    Front Immunol; 2021; 12():651728. PubMed ID: 33859644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can BCG vaccine protect against COVID-19 via trained immunity and tolerogenesis?
    Basak P; Sachdeva N; Dayal D
    Bioessays; 2021 Mar; 43(3):e2000200. PubMed ID: 33169410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 pneumonia: CD8
    Jiang Y; Wei X; Guan J; Qin S; Wang Z; Lu H; Qian J; Wu L; Chen Y; Chen Y; Lin X
    Clin Immunol; 2020 Sep; 218():108516. PubMed ID: 32574709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T Cell Memory: Understanding COVID-19.
    Jarjour NN; Masopust D; Jameson SC
    Immunity; 2021 Jan; 54(1):14-18. PubMed ID: 33406391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes.
    Sánchez-Cerrillo I; Landete P; Aldave B; Sánchez-Alonso S; Sánchez-Azofra A; Marcos-Jiménez A; Ávalos E; Alcaraz-Serna A; de Los Santos I; Mateu-Albero T; Esparcia L; López-Sanz C; Martínez-Fleta P; Gabrie L; Del Campo Guerola L; de la Fuente H; Calzada MJ; González-Álvaro I; Alfranca A; Sánchez-Madrid F; Muñoz-Calleja C; Soriano JB; Ancochea J; Martín-Gayo E;
    J Clin Invest; 2020 Dec; 130(12):6290-6300. PubMed ID: 32784290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Cytokines and Lymphocyte Subsets in Patients Who Have Recovered from COVID-19.
    Hasichaolu ; Zhang X; Li X; Li X; Li D
    Biomed Res Int; 2020; 2020():7570981. PubMed ID: 33274223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute SARS-CoV-2 pneumonitis with cytotoxic CD8 positive T-lymphocytes: Case report and review of the literature.
    Puzyrenko A; Felix JC; Sun Y; Rui H; Sheinin Y
    Pathol Res Pract; 2021 Apr; 220():153380. PubMed ID: 33676105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired function and delayed regeneration of dendritic cells in COVID-19.
    Winheim E; Rinke L; Lutz K; Reischer A; Leutbecher A; Wolfram L; Rausch L; Kranich J; Wratil PR; Huber JE; Baumjohann D; Rothenfusser S; Schubert B; Hilgendorff A; Hellmuth JC; Scherer C; Muenchhoff M; von Bergwelt-Baildon M; Stark K; Straub T; Brocker T; Keppler OT; Subklewe M; Krug AB
    PLoS Pathog; 2021 Oct; 17(10):e1009742. PubMed ID: 34614036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of memory T cells in COVID-19 patients and the predictive role of CD4+CD8+ double positive T lymphocytes as a new marker.
    Kalpakci Y; Hacibekiroglu T; Trak G; Karacaer C; Demirci T; Kocayigit H; Sunu C; Varim C; Falay M
    Rev Assoc Med Bras (1992); 2020 Dec; 66(12):1666-1672. PubMed ID: 33331574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Existence of SARS-CoV-2 in COVID-19 Patients: Host Immunity, Viral Virulence, and Transmissibility.
    Wang X; Huang K; Jiang H; Hua L; Yu W; Ding D; Wang K; Li X; Zou Z; Jin M; Xu S
    Virol Sin; 2020 Dec; 35(6):793-802. PubMed ID: 33156486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naturally activated adaptive immunity in COVID-19 patients.
    Yang X; Dai T; Zhou X; Qian H; Guo R; Lei L; Zhang X; Zhang D; Shi L; Cheng Y; Hu J; Guo Y; Zhang B
    J Cell Mol Med; 2020 Nov; 24(21):12457-12463. PubMed ID: 32975374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.